InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,006.87
(
-1.28%
)
US TECH 100
16,856.80
(
-1.19%
)
Dow Jones
37,830.98
(
-1.64%
)
Brent Oil
86.63
(
-0.68%
)
Bitcoin
63,568.00
(
-1.11%
)
Post# of 38376
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

$tock_Killa

Send PM Follow Ignore
Followers 28
Posts 722
Boards Moderated 1
Alias Born 12/02/2009

$tock_Killa

Re: None

Saturday, 10/11/2014 4:02:11 PM

Saturday, October 11, 2014 4:02:11 PM

Post# of 38376
ENTB = Entest believes its COPD treatment, which utilizes patent pending adult stem cell therapy coupled with photoceutical device enhancement, has the potential to reverse COPD related lung damage as well as alleviate symptoms.

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up